SCHEMBL8739807

SCHEMBL8739807

C/C(=C\c1c[nH]c2ccccc12)C(N)=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2A6 P11509 1/20 0.53
▸ IMPDH2 P12268 1/20 0.53
▸ APP P05067 1/20 0.53
▸ POLB P06746 2/20 0.52
▸ ALDH1A1 P00352 9/20 0.51
▸ KMT2A Q03164 6/20 0.51
▸ KDM4E B2RXH2 4/20 0.51
▸ GAA P10253 2/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ ATM Q13315 2/20 0.50
▸ PBRM1 Q86U86 1/20 0.50
▸ MAPT P10636 8/20 0.49
▸ MEN1 O00255 5/20 0.49
▸ HPGD P15428 4/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ NPC1 O15118 2/20 0.49
▸ RAB9A P51151 2/20 0.49
▸ NFKB1 P19838 2/20 0.49
▸ NFKB2 Q00653 1/20 0.49
▸ RELA Q04206 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15487095 0.86 CYP2A6 (0.54) CYP2A6IMPDH2APPPOLBALDH1A1
SCHEMBL15487094 0.86 CYP2A6 (0.54) CYP2A6IMPDH2APPPOLBALDH1A1
SCHEMBL25001258 0.83 APP (0.58) CYP2A6IMPDH2APPPOLBALDH1A1
SCHEMBL16445879 0.82 POLB (0.67) CYP2A6IMPDH2APPPOLBALDH1A1
SCHEMBL30734352 0.82 ALDH1A1 (0.57) CYP2A6IMPDH2APPPOLBALDH1A1
SCHEMBL22950668 0.82 ALDH1A1 (0.57) CYP2A6IMPDH2APPPOLBALDH1A1
SCHEMBL30734350 0.82 ALDH1A1 (0.57) CYP2A6IMPDH2APPPOLBALDH1A1
SCHEMBL13811016 0.80 APP (0.62) CYP2A6IMPDH2APPPOLBALDH1A1
SCHEMBL7773883 0.79 CYP2A6 (0.54) CYP2A6IMPDH2APPPOLBALDH1A1
SCHEMBL2825118 0.78 CYP2A6 (0.61) CYP2A6IMPDH2APPPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012066549-A1 DIPEPTIDE ANALOGS FOR TREATING CONDITIONS ASSOCIATED WITH AMYLOID FIBRIL FORMATION RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2012-05-24 — — WO disclosed
Send feedback